India needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, oncologist Dr Bhawna Sirohi said. A member of the new Lancet Oncology Commission on precision cancer, Sirohi flagged high testing and drug costs and urged their integration into public healthcare schemes.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.